Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Genmab EPS - Earnings per Share 2019-2020 | GMAB

Genmab annual and quarterly earnings per share history from 2019 to 2020. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Genmab EPS for the quarter ending March 31, 2020 was $0.30, a 67.78% increase year-over-year.
  • Genmab EPS for the twelve months ending March 31, 2020 was $0.63, a 72.6% decline year-over-year.
  • Genmab 2019 annual EPS was $0.51, a 72.86% decline from 2018.
  • Genmab 2018 annual EPS was $1.88, a INF% increase from .
  • Genmab annual EPS was $0, a NAN% decline from .
  
Genmab Annual EPS
2019 $0.51
2018 $1.88
Genmab Quarterly EPS
2020-03-31 $0.30
2019-12-31 $-0.39
2019-09-30 $0.62
2019-06-30 $0.10
2019-03-31 $0.18
2018-12-31 $2.13
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $22.365B $0.805B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $150.738B 16.60
Bristol Myers Squibb (BMY) United States $136.191B 11.38
Gilead Sciences (GILD) United States $96.286B 12.48
CSL (CSLLY) Australia $92.372B 0.00
Vertex Pharmaceuticals (VRTX) United States $75.530B 51.93
Regeneron Pharmaceuticals (REGN) United States $69.009B 26.60
Illumina (ILMN) United States $55.770B 57.31
Biogen (BIIB) United States $44.028B 7.54
Seattle Genetics (SGEN) United States $29.505B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.079B 10.77
Incyte (INCY) United States $23.431B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.288B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.095B 209.36
Moderna (MRNA) United States $21.958B 0.00
Genmab (GNMSF) Denmark $21.042B 62.47
Alnylam Pharmaceuticals (ALNY) United States $17.584B 0.00
BeiGene (BGNE) Cayman Islands $15.299B 0.00
BioNTech SE (BNTX) Germany $14.822B 0.00
Exact Sciences (EXAS) United States $13.345B 0.00
Galapagos (GLPG) Belgium $13.216B 38.88
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
Sarepta Therapeutics (SRPT) United States $12.750B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.086B 27.28
ARGENX SE-ADR (ARGX) Netherlands $11.082B 0.00
Bio-Techne Corp (TECH) United States $10.314B 68.14
QIAGEN (QGEN) Netherlands $9.853B 28.65
Immunomedics (IMMU) United States $9.381B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.368B 0.00
Guardant Health (GH) United States $8.062B 0.00
Ascendis Pharma (ASND) Denmark $7.288B 0.00
Exelixis (EXEL) United States $7.096B 24.88
Repligen (RGEN) United States $6.621B 116.14
Adaptive Biotechnologies (ADPT) United States $5.960B 0.00
Acceleron Pharma (XLRN) United States $5.463B 0.00
Reata Pharmaceuticals (RETA) United States $5.332B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.212B 112.15
Ultragenyx Pharmaceutical (RARE) United States $5.175B 0.00
Mirati Therapeutics (MRTX) United States $5.078B 0.00
Vir Biotechnology (VIR) United States $4.836B 0.00
Zai Lab (ZLAB) China $4.782B 0.00
Novavax (NVAX) United States $4.604B 0.00
Emergent Biosolutions (EBS) United States $4.497B 29.47
MorphoSys AG (MOR) Germany $4.341B 33.67
MyoKardia (MYOK) United States $4.306B 0.00
Blueprint Medicines (BPMC) United States $4.298B 0.00
China Biologic Products (CBPO) China $4.176B 23.22
Global Blood Therapeutics (GBT) United States $4.116B 0.00
Amicus Therapeutics (FOLD) United States $4.020B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.877B 0.00
Halozyme Therapeutics (HALO) United States $3.801B 0.00
NeoGenomics (NEO) United States $3.660B 267.31
Inovio Pharmaceuticals (INO) United States $3.309B 0.00
Bluebird Bio (BLUE) United States $3.232B 0.00
Arena Pharmaceuticals (ARNA) United States $3.197B 0.00
Alkermes (ALKS) Ireland $3.116B 61.34
Deciphera Pharmaceuticals (DCPH) United States $3.076B 0.00
Insmed (INSM) United States $2.897B 0.00
Fate Therapeutics (FATE) United States $2.859B 0.00
Denali Therapeutics (DNLI) United States $2.694B 0.00
Amarin (AMRN) Ireland $2.691B 0.00
PHARMA MAR SA (PHMMF) Spain $2.379B 0.00
Viela Bio (VIE) United States $2.254B 0.00
UniQure (QURE) Netherlands $1.986B 0.00
Twist Bioscience (TWST) United States $1.913B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.906B 0.00
Principia Biopharma (PRNB) United States $1.893B 0.00
Eidos Therapeutics (EIDX) United States $1.884B 0.00
Ligand Pharmaceuticals (LGND) United States $1.827B 71.14
Alector (ALEC) United States $1.800B 0.00
Editas Medicine (EDIT) United States $1.694B 0.00
Zymeworks (ZYME) Canada $1.690B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.683B 0.00
Adverum Biotechnologies (ADVM) United States $1.643B 0.00
Epizyme (EPZM) United States $1.598B 0.00
I-Mab (IMAB) China $1.567B 0.00
Intra-Cellular Therapies (ITCI) United States $1.565B 0.00
Mesoblast (MESO) Australia $1.531B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.519B 0.00
Beam Therapeutics (BEAM) United States $1.515B 0.00
Sorrento Therapeutics (SRNE) United States $1.502B 0.00
Revance Therapeutics (RVNC) United States $1.494B 0.00
Mersana Therapeutics (MRSN) United States $1.487B 0.00
Zealand Pharma (ZEAL) Denmark $1.472B 0.00
Cytokineticsorporated (CYTK) United States $1.448B 0.00
Akcea Therapeutics (AKCA) United States $1.428B 0.00
Sangamo Therapeutics (SGMO) United States $1.385B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
REGENXBIO (RGNX) United States $1.349B 0.00
Arvinas (ARVN) United States $1.329B 0.00
NGM Biopharmaceuticals (NGM) United States $1.295B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.232B 0.00
NantKwest (NK) United States $1.168B 0.00
Intellia Therapeutics (NTLA) United States $1.156B 0.00
Athenex (ATNX) United States $1.114B 0.00
Arcus Biosciences (RCUS) United States $1.106B 0.00
Compugen (CGEN) Israel $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.957B 0.00
Alcobra (ARCT) United States $0.946B 0.00
Retrophin (RTRX) United States $0.887B 0.00
Myriad Genetics (MYGN) United States $0.884B 45.62
Heska (HSKA) United States $0.866B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Pharming Group (PHGUF) Netherlands $0.826B 22.00
Cara Therapeutics (CARA) United States $0.822B 0.00
Cellectis S.A (CLLS) France $0.809B 0.00
Morphic Holding (MORF) United States $0.790B 0.00
Intrexon (PGEN) United States $0.787B 0.00
Dynavax Technologies (DVAX) United States $0.781B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.748B 0.00
Kadmon Holdings (KDMN) United States $0.733B 0.00
Codexis (CDXS) United States $0.731B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.692B 0.00
Castle Biosciences (CSTL) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.683B 0.00
Vericel (VCEL) United States $0.668B 123.33
Agenus (AGEN) United States $0.663B 0.00
Cue Biopharma (CUE) United States $0.641B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.641B 5.49
Sinovac Biotech (SVA) China $0.640B 20.87
VBI Vaccines (VBIV) United States $0.639B 0.00
AnaptysBio (ANAB) United States $0.606B 0.00
MiMedx (MDXG) United States $0.597B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.576B 0.00
Kala Pharmaceuticals (KALA) United States $0.575B 0.00
NextCure (NXTC) United States $0.564B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.551B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.545B 0.00
Anika Therapeutics (ANIK) United States $0.541B 17.41
Syndax Pharmaceuticals (SNDX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.532B 0.00
Athersys (ATHX) United States $0.529B 0.00
Syros Pharmaceuticals (SYRS) United States $0.524B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.520B 0.00
UROGEN PHARMA (URGN) United States $0.520B 0.00
Scholar Rock Holding (SRRK) United States $0.509B 0.00
Clovis Oncology (CLVS) United States $0.502B 0.00
Protagonist Therapeutics (PTGX) United States $0.495B 0.00
DBV Technologies S.A (DBVT) France $0.495B 0.00
AC Immune SA (ACIU) Switzerland $0.464B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.462B 0.00
MeiraGTx Holdings (MGTX) United States $0.455B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
BioDelivery Sciences (BDSI) United States $0.449B 23.60
Geron (GERN) United States $0.433B 0.00
Precision BioSciences (DTIL) United States $0.426B 0.00
Prothena (PRTA) Ireland $0.426B 0.00
Puma Biotechnology (PBYI) United States $0.422B 0.00
Avid Bioservices (CDMO) United States $0.397B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.395B 0.00
Albireo Pharma (ALBO) United States $0.395B 0.00
ANI Pharmaceuticals (ANIP) United States $0.379B 7.52
Kamada (KMDA) Israel $0.377B 15.67
CytomX Therapeutics (CTMX) United States $0.377B 0.00
MannKind (MNKD) United States $0.371B 0.00
Seres Therapeutics (MCRB) United States $0.370B 0.00
WAVE Life Sciences (WVE) Singapore $0.348B 0.00
OSMOTICA PHARM (OSMT) United States $0.345B 0.00
PDL BioPharma (PDLI) United States $0.341B 293.00
Affimed (AFMD) Germany $0.331B 0.00
Prometic Life Sciences (LMNL) Canada $0.321B 0.00
Cellular Biomedicine (CBMG) United States $0.320B 0.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Celldex Therapeutics (CLDX) United States $0.284B 0.00
Pfenex (PFNX) United States $0.284B 0.00
Spero Therapeutics (SPRO) United States $0.284B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.284B 0.00
Menlo Therapeutics (MNLO) United States $0.277B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.274B 0.00
Verastem (VSTM) United States $0.262B 0.00
Abeona Therapeutics (ABEO) United States $0.260B 0.00
IVERIC Bio (ISEE) United States $0.260B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.260B 0.00
Northwest Biotherapeutics (NWBO) United States $0.252B 0.00
Gritstone Oncology (GRTS) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.243B 0.00
Selecta Biosciences (SELB) United States $0.240B 0.00
HOOKIPA Pharma (HOOK) United States $0.237B 0.00
IBio (IBIO) United States $0.237B 0.00
Dyadic (DYAI) United States $0.232B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.226B 0.00
Pluristem Therapeutics (PSTI) Israel $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.224B 0.00
Five Prime Therapeutics (FPRX) United States $0.223B 0.00
XOMA (XOMA) United States $0.222B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Exicure (XCUR) United States $0.218B 0.00
Aptinyx (APTX) United States $0.216B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
Aduro Biotech (ADRO) United States $0.207B 0.00
Strongbridge Biopharma (SBBP) United States $0.207B 0.00
Bellus Health (BLU) Canada $0.205B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Sutro Biopharma (STRO) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.191B 0.00
Trevena (TRVN) United States $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.169B 0.00
Aytu Bioscience (AYTU) United States $0.165B 0.00
Cyclerion Therapeutics (CYCN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.159B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Theratechnologies (THTX) Canada $0.157B 0.00
Cerecor (CERC) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
VolitionRX (VNRX) United States $0.151B 0.00
Biofrontera AG (BFRA) Germany $0.149B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.133B 0.00
PHASEBIO PHARMA (PHAS) United States $0.131B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.129B 0.00
Celsion (CLSN) United States $0.124B 0.00
Oncobiologics (OTLK) United States $0.120B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.119B 0.00
AIT Therapeutics (XAIR) United States $0.119B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.99
Eton Pharmaceuticals (ETON) United States $0.113B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
AquaBounty Technologies (AQB) United States $0.103B 0.00
DiaMedica Therapeutics (DMAC) United States $0.100B 0.00
Windtree Therapeutics (WINT) United States $0.097B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.087B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
Cardiff Oncology (CRDF) United States $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.077B 0.00
AnPac Bio-Medical Science (ANPC) China $0.076B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Happiness Biotech Group (HAPP) China $0.071B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Unum Therapeutics (UMRX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.067B 0.00
Stealth BioTherapeutics (MITO) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Signal Genetics (MGEN) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.047B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
Prima BioMed (IMMP) Australia $0.041B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.039B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.033B 0.00
OvaScience (MLND) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.031B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.029B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Evogene (EVGN) Israel $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.025B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Cleveland BioLabs (CBLI) United States $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
VIVUS (VVUS) United States $0.014B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00